Asset Details
Do you wish to reserve the book?
Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
Do you wish to request the book?
Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
2025
Overview
Bovine tuberculosis (BTB) is an infectious disease of livestock and wildlife species that is caused by pathogenic members of the
Mycobacterium tuberculosis
complex such as
Mycobacterium bovis
. Due to the introduction of
M. bovis
-infected bison in the 1920s, BTB is now endemic in wood bison (
Bison bison athabascae
) population within the Wood Buffalo National Park (WBNP) in northern Canada. This disease poses a grave threat to the long-term survival of this ecologically and culturally important species and has the potential to cause zoonotic TB and spill over to BTB-free livestock and other bison herds that live in the surrounding areas. Thus, effective BTB control strategies in WBNP bison are urgently needed. To this end, we aerosol challenged young bison with different doses of virulent
M. bovis
and observed disease-associated delayed-type hypersensitivity, gross lung and lymph node pathology and histopathology, as well as
M. bovis
burden in target organs, thus confirming the establishment of BTB in challenged animals. We then assessed the safety and efficacy of oral live BCG versus oral heat-inactivated
M. bovis
(HIMB) given in a homologous prime-boost regimen in bison. While both BCG and HIMB offered protection against BTB, BCG-treated bison thrived more, presented with fewer lung lesions at necropsy and lower burden of virulent
M. bovis
than HIMB-treated animals. Strikingly, oral HIMB induced almost no delayed-type hypersensitivity to intradermal tuberculin while oral live BCG induced very low sensitivity to tuberculin in bison, indicating their potential as DIVA (differentiating infected from vaccinated animals) vaccines for use in this important wildlife species.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/326
/ 692/420
/ 692/699
/ Animals
/ BCG Vaccine - administration & dosage
/ Bison
/ Cattle
/ DIVA
/ Humanities and Social Sciences
/ Live BCG
/ Mycobacterium bovis - immunology
/ Necropsy
/ Science
/ Tuberculosis, Bovine - immunology
/ Tuberculosis, Bovine - microbiology
/ Tuberculosis, Bovine - prevention & control
/ Vaccines, Inactivated - administration & dosage
/ Vaccines, Inactivated - immunology
/ Wildlife
/ Zoonoses
